The outpatient thrombosis prevention study was halted as the researchers concluded that among mildly symptomatic but clinically stable COVID 19 outpatients a week or more since the time of diagnosis, rates of major cardio pulmonary complications are very low and do not justify preventive anticoagulant or antiplatelet therapy unless otherwise clinically indicated <a href=http://cial.buzz>cialis for sale</a>